PATENT CLAIM ANALYSIS

Application Number: 16028228
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-12
Patent Classification: ["514", "252120"]

Abstract:
The present invention provides a composition and method for treating acute on chronical liver failure or a related disease. The method comprises administering to a subject a composition comprising trimetazidine hydrochloride (1-[2,3,4-trimethoxybenzyl] piperazine dihydrochloride) (Trimetazidine or TMZ) or a pharmaceutically acceptable salt thereof according to a dosage regimen.

Claim (Index 25):
The method according to  claim 24 , wherein the formulation is structured to provide a burst release release of 30 mg to 180 mg of TMZ following administration of the TMZ to a patient.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 95.0
- Lexical Diversity: 1.32558
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14891746', '15092533', '11602571', '14326075', '12713497']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7100552242229077
- 35 USC 102 Novelty (BERT): 0.5175182238254683
- Combined Prediction Score: 0.6908015241831638
- Mean Citation Score: 190.156372
- Max Citation Score: 196.69803
- Similarity Product: 99.52734729930106

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test